US approves Bavencio for bladder cancer
In a clinical trial, Bavencio maintenance treatment extended median overall survival by 50% over standard of care
Read More
Tag: JAVELIN 100
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
